6/13
07:30 am
huge
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
High
Report
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
6/4
07:30 am
huge
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
Medium
Report
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
5/31
07:30 am
huge
FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
Low
Report
FSD Pharma, Inc. Wins Petition to Confirm Arbitration Awards Entered Against Dr. Raza Bokhari Totaling Over $3 Million CAD, Plus Interest
5/28
08:00 am
huge
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
Low
Report
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
5/24
05:24 pm
huge
FSD Pharma Provides Corporate Update [Yahoo! Finance]
Low
Report
FSD Pharma Provides Corporate Update [Yahoo! Finance]
5/16
08:00 am
huge
FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
Medium
Report
FSD Pharma Provides Update on Celly Nu's New Packaging for unbuzzd(TM)
5/16
07:56 am
huge
Celly Nutrition Corp and Six+One Unveil New Packaging and Logo for unbuzzd(TM) Expected Launch This Summer [Yahoo! Finance]
Medium
Report
Celly Nutrition Corp and Six+One Unveil New Packaging and Logo for unbuzzd(TM) Expected Launch This Summer [Yahoo! Finance]
5/9
06:02 am
huge
FSD Pharma Inc. (NASDAQ: HUGE) had its "buy-venture" rating re-affirmed by analysts at Singular Research.
Medium
Report
FSD Pharma Inc. (NASDAQ: HUGE) had its "buy-venture" rating re-affirmed by analysts at Singular Research.
5/7
08:30 am
huge
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
Low
Report
FSD Pharma Submits a Phase-1 Multiple Ascending Doses Clinical Trial Application for Lucid-21-302 (Lucid-MS) for Ethics Committee Review in Australia
4/30
08:33 am
huge
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
Medium
Report
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol Intoxication
4/25
07:47 am
huge
FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)
High
Report
FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)
4/22
08:13 am
huge
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]
Medium
Report
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]
4/22
08:00 am
huge
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)
Medium
Report
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)
4/17
08:10 am
huge
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products [Yahoo! Finance]
Medium
Report
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products [Yahoo! Finance]
4/17
08:00 am
huge
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
High
Report
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products
4/15
08:13 am
huge
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption [Yahoo! Finance]
High
Report
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption [Yahoo! Finance]
4/15
08:00 am
huge
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption
High
Report
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption
4/8
08:27 pm
huge
Celly Announces Increase of Term Loan [Yahoo! Finance]
Medium
Report
Celly Announces Increase of Term Loan [Yahoo! Finance]
4/7
11:07 pm
huge
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency [Yahoo! Finance]
Medium
Report
FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency [Yahoo! Finance]
4/1
10:00 pm
huge
FSD Pharma Announces Filing of Year-End 2023 Results
Low
Report
FSD Pharma Announces Filing of Year-End 2023 Results
3/27
08:00 am
huge
FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults
Low
Report
FSD Pharma Signs the Agreement With iNGENu CRO To Conduct a Clinical Study To Assess the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 (Lucid-MS) in Healthy Adults